newsfilter
← Latest News
ACCESS Newswire·

Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens

Positive Findings Support Potential Expanded Uses for ParidiprubartTORONTO, ON / ACCESSWIRE / June 28, 2023 / Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on inflammatory and